clopidogrel 23andMe Begins Reporting PGx Variants With Drug Info Under Recent FDA Clearance Premium The new reports link variants in CYP2C19 to the safety and efficacy of two drugs, a commonly prescribed antiplatelet drug and an antidepressant. Meta-Analysis Supports Pharmacogenomic Testing Prior to Anti-Platelet Therapy The study showed that CYP2C19 genotyping could help clinicians reduce ischemic events in patients with coronary artery disease by tailoring their treatment. FDA Joins PGx Collaborative Community but Effect on Field is Unclear Premium The community is poised to be the primary channel for stakeholders to communicate PGx concerns with FDA, but it is unclear if all stakeholders will participate. Trial Shows Some Benefit of Genetically Guided Antiplatelet Therapy After Balloon Angioplasty The TAILOR-PCI trial did not meet its primary endpoint but did find that genetic testing led to a reduction in adverse events, though not as much as expected. 23andMe Garners FDA Clearance for CYP2C19 PGx Test Report The firm can now tell customers if their genotypes may impact their response to clopidogrel and citalopram without the need for confirmatory testing. Jan 28, 2020 Spartan Bioscience Pushing to Commercialize Personalized Heart Test Premium Jul 8, 2015 New Analysis Examines Financial Impact of Genotyping Patients to Guide Anti-Platelet Therapy Premium Nov 5, 2014 After Health Canada Approval, Spartan Plans to Launch Point-of-Care CYP2C19 Dx via Pharmacy Pilots Premium Apr 16, 2014 Lawsuit in Hawaii against Plavix Sponsors Alleges Burden is on Pharma to Market PGx Information Premium Nov 20, 2013 In Prescribing Study, Few Doctors Altered Treatment for Poor Plavix Metabolizers Based on Genotype Premium Oct 23, 2013 Transgenomic Enlists PDI to Market Cardiac PGx Test; PDI Entering MDx Space Premium Sep 12, 2013 Mount Sinai Group Publishes Allele-Specific PCR Assay for Novel CYP2C19 Variants Premium Sep 4, 2013 Spartan to Continue Talks with FDA as it Aims for Point-of-Care Indication for CYP2C19 Test Premium Aug 29, 2013 FDA Clearance of Spartan Assay Inches CYP2C19 Genotyping Closer to Point of Care Premium Aug 21, 2013 After Plavix PGx Experience, UF Rolling Out Similar Genetic Testing Program to Community Settings Premium Mar 13, 2013 Spartan Bioscience Building Evidence for Point-of-Care PGx Testing to Guide Antiplatelet Therapy Premium Nov 14, 2012 FDA Clears Nanosphere's CYP2C19 Test to Guide Therapeutic Strategy, Not Predict Response Premium Jul 25, 2012 MDx/CDx Focus: Cepheid Updates BCR-ABL Test; Medicare Covers Transgenomic Plavix Dx; Lungevity Awards Premium Jun 28, 2012 U of Florida PGx Program Adopts Life Tech OpenArray Assays to Screen Catheterization Patients Premium Jun 27, 2012 UF to Genotype All Comers at Cath Lab to Personalize Treatment with Plavix, Eventually Other Drugs Premium May 9, 2012 Following Merger, Express Scripts May Cut Back Medco's Personalized Medicine Programs Premium Apr 4, 2012 Study: Higher Plavix Dose Doesn't Improve Response for CYP2C19*2 Carriers; Effient May Be Best Option Premium Apr 4, 2012 PGx Highlights from American College of Cardiology Annual Meeting Premium Mar 21, 2012 Exome Sequencing IDs Plavix Response Variants that Could Lead to Better PGx Test Premium Feb 15, 2012 Dx Developers' Sales Pitch to Pharma Could be Key Factor in Marketing Some Tests Premium Load More Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.